Preclinical analysis demonstrates fibroblast activation protein expression across multiple cell types in glioblastoma, highlighting its promise for dual tumor and vascular immunotherapy.
Fibroblast activation protein is expressed by multiple cell types within glioblastoma, highlighting it as an ideal immunotherapy antigen to target destruction of both tumor cells and their supporting vascular network.
No takes yet. Share an insight, caveat, or question.
Ebert et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: